Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension.

By R. de Franchis. Journal of Hepatology, 2015

2,264 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/8c3dc13878aec56275483dd1e092b6dc72764397

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

In Hepatology

Citations in the corpus

Baveno VII – Renewing consensus in portal hypertension (2021, background): “The statements are classified as unchanged, changed, and new in relation to Baveno VI. 1) HVPG as a gold standard Description of HVPG measurement 1.1.”
Easl Clinical Practice Guidelines (Cpgs) On Non-Invasive Tests For Evaluation Of Liver Disease Severity And Prognosis- 2020 Update. (2021, background): “combined to a platelet count >150 G/L led invariably to miss less than 5% high-risk varices requiring treatment [17].”
Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues. (2019, background): “…practice over the past 15 years and has not only resulted in earlier detection of patients with hepatic fibrosis, but also new models for the stratification, prognostication and treatment of patients with chronic liver diseases (EASL-ALEH Clinical Practice Guidelines, 2015; de Franchis, 2015).”
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. (2018, methodology): “Given the high prevalence of ‘high-risk varices’ in decompensated cirrhosis, oesophagogastroduodenoscopy (EGD) should be performed to detect the presence, size of varices and presence of red wale marks [168, 169].”
The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease (2020, background): “LSM < 10 kPa in the absence of other known clinical signs rules out, whereas a LSM of 10–15 kPa is suggestive, and > 15 kPa is highly suggestive of compensated advanced chronic liver disease [159].”
EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017, neutral): “Non-selective beta-blockers are indicated in patients with large oesophageal varices, which is similar to liver cirrhosis due to other causes [248]; however, patients with fatigue may find added beta-blockade challenging symptomatically.”
EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version) (2017, methodology): “Recent data indicates that if a combination of a Young’s modulus value of < 20 kPa and a platelet count of > 150 G/L is used, varices needing treatment can be ruled out with a high accuracy (< 5 % of patients missed) [242, 243], and endoscopy can be safely avoided [244].”